ORIGINAL ARTICLE

Int. J. Public Health, 17 May 2022

Volume 67 - 2022 | https://doi.org/10.3389/ijph.2022.1604785

Association of all Cause and Cause-Specific Mortality With Hearing Loss Among US Adults: A Secondary Analysis Study

  • Department of Epidemiology and Medical Statistics, Xiangya School of Public Health, Central South University, Changsha, China

Article metrics

2

Citations

2,6k

Views

780

Downloads

Abstract

Objectives: Previous research revealed the relationship between hearing loss (HL) and all cause mortality. The aim of this study was to determine the association between HL and all causes and cause-specific mortality based on US adults.

Methods: Data were obtained by linking National Health Interview Survey (NHIS) (2004–2013) with linkage to a mortality database to 31 December 2015. HL were categorized into four groups: good hearing, a little hearing difficulty, a lot of hearing difficulty, profoundly deaf. The relationship between HL and mortality risk was analyzed using Cox proportional hazards regression model.

Results: Compared with the reference group (Good), those who had light or moderate hearing problems were at an increased risk of mortality for all causes (A little trouble—HR: 1.17; 95% confidence interval [CI]: 1.13 to 1.20; A lot of trouble—HR: 1.45; 95% CI: 1.40–1.51); deaf—HR: 1.54; 95% CI: 1.38–1.73) respectively.

Conclusion: In addition, those in the deaf category have the highest risk of death from all causes and cause-specific cancer. More older adults are associated with an increased risk of all-cause mortality in American adults.

Introduction

Hearing loss (HL) is not just one of the causes of disability, but also affects 360 million people in the world [1]. The most recent WHO estimate suggests that approximately 466 million people (or 6.1% of the world’s population) were living with disabling hearing loss in 2018 [2]. HL is also a common social problem and one of chronic diseases in the US [3]. As the third most chronic disability in the US, HL is estimated to affect 29 million Americans. The adult population of HL accounts for approximately 16.8% of the US population. Its prevalence also has risen significantly and increases with age [46]. As the population age and noise exposure increases, the incidence of HL may be also growing [3, 7, 8]. The Global Burden of Disease study estimated that the population with hearing loss increased from 1.2 billion (17.2%) in 2008 to 1.4 billion (18.7%) in 2017 [9]. The prevalence of hearing loss is rising year by year [10]. The prevalence of HL among US adults over the age of 65 ranges from 30% to 83% [11, 12]. With the aging population in the US increasing, the number of people suffering from HL is also increasing, which may gradually become a public health problem [13].

Researchers have concluded that there is a relationship between HL and increased mortality risks [1417]. A recent study showed that older people with severe HL have a 20% increased risk of death compared to people with normal hearing [18]. In addition, a number of studies have shown that HL has a significant negative impact on the health status, social isolation and physical functions of the older adults [1927]. One of the studies presented that HL can also cause communication difficulties, which not only affect work efficiency, but also negatively affect cognition and emotions [1924]. HL closely interacts with health. HL can cause many problems, and communication barriers that accompany HL may lead to disability and psychological inferiority, which results in lower self-esteem and even worsen mental health [25, 26]. At the same time, a recent study also found a longitudinal relationship between HL and depression [27].

There are also several studies have found that HL is associated with all-cause mortality and other cause-specific mortality, such as deaths due to influenza and pneumonia disease or chronic lower respiratory disease (CLRD) [28, 29]. Result from evidence suggests that viral and pneumonia infection could be one factor of HL [28]. While most studies are limited to the association of hearing loss with all-cause mortality, our study analyzed all-cause mortality and further discussed hearing loss and cause-specific mortality. In addition, National Health Interview Survey (NHIS) has received approval from the National Center for Health Statistics (NCHS) Research Ethics Review Board, which is based on a secondary analysis of publicly available, de-identified data. The aim of this article is to analyze hearing loss on cause-specific mortality (CVD; heart disease; and stroke; CLRD; cancer; diabetes; Alzheimer’s disease; influenza and pneumonia; and accidents).

Methods

Data Source

The data for this study comes from the National Health Interview Survey (NHIS) (2004–2013) in the United States, which is a representative, stratified, multistage probability survey. The US Centers for Disease Control and Prevention and the NCHS conducted annual household interview surveys through the Census Bureau and collected the basic health status of family members. Participants are members of the US population living in different communities. The specific design and method are all in NCHS (www.cdc.gov/nchs/nhis/about_nhis.htm; accessed 7 January 2018). The data is public and in compliance with the ethical board review of the corresponding author’s institution.

Study Participants

This study included representative US adult data collected in every household from 2004 to 2013. The complete reported hearing loss data was available for a total of 493,036 participants over 18 years of age who met the criteria for this study. Among them, 37,048 were excluded because of missing data on diabetes (n = 200), missing data on smoking and drinking (n = 8,524), missing data on physical activity (n = 11,119) and missing data on potential covariates (personal variables, lifestyle factors or chronic health conditions; n = 17,205), resulting in the final analytical sample of 455,988 adults.

Study Outcomes

The mortality rate is recorded by the National Death Index (NDI). It has showed that the accuracy of all-cause mortality and cause-specific mortality is consistent with NDI records [30, 31]. Cause of death is coded using the International Classification of Diseases (ICD-10) In addition to all-cause mortality, there are mainly outcomes of cause-specific mortality (CVD; heart disease; and stroke; CLRD; cancer; Diabetes; Alzheimer’s disease; Influenza and pneumonia; and accidents). See Supplementary Table SA for the ICD-10 codes.

Study Exposure

Hearing loss status was ascertained at the initial interview via two binary coded (i.e., yes/no) items: 1) Can you hear what other people are saying when you talk to them. 2) Do family members and friends think you have difficulty hearing. Those participants responding “Yes” to the first item and “No” the second item were classified as good. Those participants responding “No” to both questions were classified as a little hearing difficulty. Those participants responding “No” to the first item and “Yes” the second item were classified as a lot of hearing difficulty. In the present study, the participants were divided according to their general hearing status, ICD-10 codes were used by the NCHS to classify hearing status as follows: as follows: 1) good hearing, 2)a little hearing difficulty, 3)a lot of hearing difficulty, 4)profoundly deaf.

Covariates

Information on covariates about sociodemographic factors and lifestyle factors at baseline was obtained via examination and questionnaire-based interviews: (1) Sociodemographic factors: age (1∼18–45, 2∼45–65, 3∼65+), sex (1∼male, 2∼female), educational level (1∼Less than high school degree, 2∼High school degree, 3∼More than high school degree) (2) Lifestyle factors as follows: Alcohol intake 1∼Lifetime abstainer, 2∼Former drinker 3∼Current drinker), Smoking status (1∼Never cigarette, 2∼Former cigarette, 3∼Current cigarette), BMI (1∼<25, 2∼25–30, 3∼≥30). In addition, we included physical activity, hypertension, diabetes, stroke, coronary heart disease (CHD), or cancer. Age, sex, race, education level, income, alcohol intake, smoking status, and BMI all were treated as categorical variables.

Statistical Analyses

Descriptive statistics were used to describe the distribution of parameters and baseline characteristics of US participants’ HL. We used the χ2 test to assess the baseline characteristics of participants in the four levels (good, a little trouble, a lot of trouble, deaf) of hearing loss. Chi-square independence test is used to check the classification difference of the weighted percentage of hearing loss. Among this, HL mortality is divided into three age groups according to the NHIS population: 18–45 years old, 45–65 years old, and >65 years and older. We used a multivariate Cox proportional hazards regression model with proportional assumptions to examine the hazard ratios (HR) with 95% CIs for all cause and cause-specific mortality for a little trouble hearing, a lot of trouble hearing, and deaf. To assess the different potential confounding effects on the relationship between levels of HL and mortality, we developed four models by incorporating three sets of covariates into the model in turn. We also conducted a subgroup analysis for all special cause mortality rates at the same time. In order to test the stability of the results, we conducted sensitivity analyses. Including participants with chronic diseases had little effect on risk estimates of all-cause mortality were excluded and all deaths within 2 years of follow-up were excluded.

All data analyses were weighted and conducted using STATA version 12.0 (Stata Corp, College Station, TX, United States). A two tailed p < 0.05 was considered to be statistically significant.

Results

Population Characteristics

Among 455,988 US adults, there are 380,233 in good status, 62,491 are regarded as a little trouble hearing, 12,044 are a lot of trouble hearing, and 1,220 are in the deaf category. Of these participants, those with hearing loss were more likely to be older, men, Non-Hispanic White, more than a high school degree, coming from a middle income status, physically inactive, current drinkers. Table 1 shows the baseline characteristics of hearing loss among participants aged 18 years and older. Each baseline feature has statistically significant differences in the four categories of HL (p < 0.001).

TABLE 1

Characteristics Overall Good Little trouble A lot of trouble Deaf
(N = 455,988) (n = 380,233) (n = 62,491) (n = 12,044) (n = 1,220)
Age group (years)
 18–45 222,402 (51.1) 206,571 (56.6) 14,198 (24.9) 1,391 (12.7) 242 (22.6)
 45–65 143,570 (32.4) 117,087 (31.3) 22,891 (39.8) 3,294 (30.5) 298 (24.9)
 65- 90,016 (16.4) 56,575 (12.1) 25,402 (35.3) 7,359 (56.9) 680 (52.5)
Sex
 Male 202,486 (48.7) 162,696 (46.9) 32,618 (57.3) 6,580 (60.7) 592 (54.9)
 Female 253,502 (51.3) 217,537 (53.1) 29,873 (42.7) 5,464 (39.3) 628 (45.1)
Race
 Hispanic 77,826 (12.6) 71,054 (13.8) 5,733 (6.5) 894 (4.9) 145 (8.5)
 Non-Hispanic White 288,763 (70.9) 229,087 (68.3) 48,762 (83.8) 9,977 (87.7) 937 (82.1)
 Non-Hispanic Black 66,797 (11.6) 59,915 (12.6) 5,980 (6.7) 811 (4.7) 91 (5.6)
 Non-Hispanic Other 22,602 (4.9) 20,177 (5.3) 2016 (3.1) 362 (2.7) 47 (3.9)
Education level
 Less than high school degree 86,014 (16.2) 68,481 (15.4) 13,443 (18.5) 3,678 (27.8) 412 (29.9)
 High school degree 126,684 (28.4) 103,341 (27.8) 19,141 (31.4) 3,810 (32.8) 392 (33.6)
 More than high school degree 243,290 (55.4) 208,411 (56.8) 29,907 (50.1) 4,556 (39.4) 416 (36.5)
Income
 Low 74,336 (12.2) 62,776 (12.4) 9,279 (11.2) 2,048 (13.1) 233 (14.0)
 Middle 232,707 (49.6) 190,776 (48.7) 33,871 (52.5) 7,301 (59.8) 759 (62.5)
 High 148,945 (38.2) 126,681 (38.9) 19,341 (36.4) 2,695 (27.1) 228 (23.4)
BMI (kg/m2)
 <25 181,028 (39.8) 154,804 (41.1) 21,151 (32.4) 4,535 (35.2) 538 (43.8)
 25–30 159,252 (35.1) 131,401 (34.6) 23,105 (37.6) 4,363 (37.3) 383 (32.7)
 >30 115,708 (25.2) 94,028 (24.3) 18,235 (30.0) 3,146 (27.6) 299 (23.5)
Physical activity
 Yes 193,133 (44.5) 166,508 (45.9) 23,086 (39.3) 3,215 (28.3) 324 (27.3)
 No 262,855 (55.5) 213,725 (54.1) 39,405 (60.7) 8,829 (71.7) 896 (72.7)
Smoking status
 Never cigarette 257,463 (56.5) 223,799 (59.0) 27,893 (44.0) 5,128 (40.3) 730 (52.6)
 Former cigarette 100,580 (22.2) 74,762 (19.7) 20,873 (34.1) 4,880 (39.7) 413 (31.3)
 Current cigarette 97,945 (21.3) 81,672 (21.3) 13,725 (21.9) 2,529 (20.0) 230 (16.1)
Alcohol intake
 Lifetime abstainer 104,467 (21.7) 88,918 (22.4) 12,014 (17.3) 3,090 (23.2) 445 (35.2)
 Former drinker 70,739 (14.7) 52,902 (13.1) 14,074 (21.4) 3,465 (28.9) 298 (23.7)
 Current drinker 280,782 (63.6) 238,413 (64.5) 36,403 (61.3) 5,489 (47.8) 447 (41.1)
Physician-diagnosed disease
 Hypertension
  Yes 325,811 (26.6) 95,007 (23.1) 28,263 (43.0) 6,351 (51.6) 556 (44.0)
  No 130,177 (73.5) 285,226 (76.9) 34,228 (57.0) 5,693 (48.4) 664 (56.0)
 Diabetes
  Yes 37,187 (7.5) 26,132 (6.2) 8,772 (13.3) 2082 (18.0) 201 (17.5)
  No 418,801 (92.5) 354,101 (93.8) 53,719 (86.7) 9,962 (82.0) 1,019 (82.5)
 CHD
  Yes 20,615 (4.2) 12,111 (2.9) 6,347 (9.8) 1979 (17.0) 178 (14.2)
  No 435,373 (95.8) 368,122 (97.1) 56,144 (90.3) 10,065 (83.0) 1,042 (85.8)
 Stroke
  Yes 12,931 (2.5) 8,374 (1.8) 4,122 (5.4) 1,431 (10.9) 140 (10.0)
  No 443,057 (97.5) 372,543 (98.3) 58,700 (94.6) 10,716 (89.1) 1,098 (90.0)
 Cancer
  Yes 35,427 (7.5) 23,570 (5.9) 9,202 (14.3) 2,448 (20.4) 207 (17.7)
  No 420,561 (92.6) 356,663 (94.1) 53,289 (85.7) 9,596 (79.6) 1,013 (82.4)

Baseline Characteristics of Hearing loss Among Participants Aged 18 Years and Older, (United States, 2004–2013).

CHD, coronary heart disease.

Hearing Loss and All Cause, Cause Specific Mortality

Table 2 displays the HR of all cause and specific-cause mortality caused by HL. After several years of 479, 856 follow-up, 59,791 participants died from all causes, 13,488 from CVD deaths (10,418 deaths related to heart disease and 3,070 deaths related to stroke disease), 14,317 from cancer deaths, 3,175 from chronic lower respiratory diseases, 2,490 from accidents, 1,478 from Alzheimer’s disease, 1,804 from diabetes, 1,133 from influenza and pneumonia. In unadjusted Model 1, HL had a greater risk of all cause, CVD disease, Alzheimer’s disease, and influenza and pneumonia disease. In comparison to those good hearing, the HR of all-cause mortality were higher in little trouble hearing 2.70 (95% CI, 2.63–2.77) a lot of trouble hearing 5.46 (95% CI, 5.24–5.69) and deaf 5.29 (95% CI, 4.72–5.94). After adjusting the covariates for all-cause mortality in Model 4, the risk of death for people with a little trouble hearing decreased from 2.70 to 1.17. A large number of HL adults have a significant reduction from 5.46 to 1.45, for deaf adults, from 5.29 to 1.54. In addition, after adjusting from model 1 to model 2 (age), the risk of mortality from all nine specific-causes of disease has been greatly reduced. Similar associations were observed between HL and all cause and specific-cause mortality (Figure 1).

TABLE 2

Outcome Number of deaths Model 1 Model 2 Model3 Model4
HR (95%CI) p HR (95%CI) p HR (95%CI) p HR (95%CI) p
All cause 59,791
Good 38,956 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00
Little trouble 15,197 2.70 (2.63–2.77) 0.00 1.32 (1.29–1.35) 0.00 1.21 (1.18–1.24) 0.00 1.17 (1.13–1.20) 0.00
A lot of trouble 5,156 5.46 (5.24–5,69) 0.00 1.93 (1.86–2.00) 0.00 1.58 (1.53–1.65) 0.00 1.45 (1.40–1.51) 0.00
Deaf 482 5.29 (4.72–5.94) 0.00 2.13 (4.75–4.90) 0.00 1.66 (1.48–1.85) 0.00 1.54 (1.38–1.73) 0.00
Cancer death 14,371 Model 1 Model 2 Model 3 Model 4
Good 9,932 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00
Little trouble 3,377 2.37 (2.27–2.48) 0.00 1.22 (1.17–1.28) 0.00 1.11 (1.06–1.17) 0.00 1.05 (1.00–1.10) 0.00
A lot of trouble 980 4.08 (3.78–4.41) 0.00 1.52 (1.41–1.64) 0.00 1.29 (1.19–1.39) 0.00 1.17 (1.08–1.27) 0.00
Deaf 82 3.63 (2.85–4.63) 0.00 1.55 (1.23–1.95) 0.00 1.29 (1.02–1.64) 0.00 1.19 (0.94–1.51) 0.00
CVD death 13,488 Model 1 Model 2 Model 3 Model 4
Good 8,374 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00
Little trouble 3,653 3.09 (2.95–3.25) 0.00 1.38 (1.31–1.44) 0.00 1.24 (1.18–1.31) 0.00 1.19 (1.13–1.25) 0.00
A lot of trouble 1,351 6.81 (6.31–7.34) 0.00 2.12 (1.98–2.27) 0.00 1.68 (1.56–1.82) 0.00 1.50 (1.39–1.63) 0.00
Deaf 110 6.17 (4.91–7.76) 0.00 2.28 (1.84–2.82) 0.00 1.62 (1.27–2.07) 0.00 1.49 (1.17–1.90) 0.00
Heart death 10,418 Model 1 Model 2 Model 3 Model 4
Good 6,477 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00
Little trouble 2,835 3.12 (2.96–3.30) 0.00 1.40 (1.32–1.48) 0.00 1.24 (1.17–1.31) 0.00 1.18 (1.12–1.25) 0.00
A lot of trouble 1,019 6.66 (6.13–7.24) 0.00 2.12 (1.95–2.30) 0.00 1.62 (1.48–1.77) 0.00 1.45 (1.32–1.58) 0.00
Deaf 87 6.28 (4.84–8.13) 0.00 2.32 (1.82–2.96) 0.00 1.64 (1.24–2.16) 0.00 1.50 (1.14–1.98) 0.00
Stroke death 3,070 Model 1 Model 2 Model 3 Model 4
Good 1897 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00
Little trouble 818 3.00 (2.71–3.32) 0.00 1.31 (1.19–1.45) 0.00 1.26 (1.14–1.40) 0.00 1.21 (1.09–1.34) 0.00
A lot of trouble 332 7.29 (6.25–8.51) 0.00 2.20 (1.88–2.57) 0.00 1.92 (1.64–2.24) 0.00 1.70 (1.45–1.99) 0.00
Deaf 23 5.83 (3.52–9.66) 0.00 1.94 (1.17–3.22) 0.01 1.57 (0.94–2.62) 0.08 1.42 (0.85–2.37) 0.18
Diabetes death 1,804 Model 1 Model 2 Model 3 Model 4
Good 1,029 1 (reference) 0.00 1 (reference) 1 (reference) 1 (reference) 0.00
Little trouble 430 2.43 (2.13–2.78) 0.00 1.21 (1.06–1.37) 0.01 1.01 (0.88–1.16) 0.87 0.99 (0.86–1.13) 0.85
A lot of trouble 156 5.50 (4.53–6.68) 0.00 2.04 (1.69–2.46) 0.00 1.42 (1.16–1.72) 0.00 1.31 (1.07–1.59) 0.01
Deaf 9 3.40 (1.62–7.15) 0.00 1.35 (0.68–2.69) 0.42 0.93 (0.43–1.99) 0.85 0.89 (0.42–1.91) 0.77
Alzheimer death 1,478 Model 1 Model 2 Model 3 Model 4
Good 872 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00
Little trouble 417 3.43 (2.98–3.95) 0.00 1.26 (1.10–1.45) 0.00 1.29 (1.11–1.49) 0.00 1.28 (1.10–1.48) 0.00
A lot of trouble 177 8.49 (7.05–10.23) 0.00 2.07 (1.75–2.44) 0.00 1.94 (1.61–2.33) 0.00 1.88 (1.57–2.26) 0.00
Deaf 12 6.67 (3.43–12.97) 0.00 2.00 (1.11–3.60) 0.09 1.54 (0.78–3.03)_ 0.21 1.49 (0.76–2.94) 0.25
Influandpneu death 1,133 Model 1 Model 2 Model 3 Model 4
Good 673 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00
Little trouble 328 3.40 (2.89–4.00) 0.00 1.43 (1.23–1.68) 0.00 1.44 (1.22–1.70) 0.00 1.41 (1.20–1.67) 0.00
A lot of trouble 115 6.84 (5.50–8.51) 0.00 2.17 (1.76–2.67) 0.00 1.79 (1.43–2.25) 0.00 1.70 (1.35–2.14) 0.00
Deaf 17 9.25 (4.63–18.48) 0.00 3.33 (1.86–5.97) 0.00 2.49 (1.25–4.96) 0.01 2.38 (1.20–4.74) 0.01
CLRD death 3,175 Model 1 Model 2 Model 3 Model 4
Good 1914 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00
Little trouble 897 3.30 (3.00–3.62) 0.00 1.44 (1.31–1.58) 0.00 1.29 (1.17–1.42) 0.00 1.26 (1.14–1.39) 0.00
A lot of trouble 331 7.29 (6.34–8.39) 0.00 2.15 (1.88–2.47) 0.00 1.75 (1.52–2.01) 0.00 1.65 (1.44–1.90) 0.00
Deaf 33 7.22 (4.66–11.18) 0.00 2.37 (1.60–3.56) 0.00 1.85 (1.19–2.85) 0.01 1.76 (1.14–2.72) 0.01
Accidents death 2,490 Model 1 Model 2 Model 3 Model 4
Good 1874 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00 1 (reference) 0.00
Little trouble 462 1.54 (1.36–1.76) 0.00 1.23 (1.09–1.40) 0.03 1.11 (0.94–1.23) 0.11 1.08 (0.94–1.23) 0.27
A lot of trouble 137 2.79 (2.23–3.48) 0.00 1.93 (1.56–2.40) 0.00 1.58 (1.17–1.86) 0.00 1.47 (1.17–1.86) 0.00
Deaf 17 2.82 (1.24–6.44) 0.01 1.97 (0.87–4.34) 0.09 1.69 (0.71–3.64) 0.21 1.61 (0.71–3.64) 0.26

Hazard ratios and 95% Confidence Interval of hearing loss for All-Cause and Cause-Specific Mortality, (United States, 2004–2013).

Model 1 unadjusted. Model 2: Adjusted for age. Model 3: Additional adjustment for education, physical activity, smokers, Alcohol intakes, BMI, hypertension, diabetes. Model 4: cancer, stroke, CHD. CVD, cardiovascular disease; CI, confidence interval; HR, hazard ratio; CLRD, chronic lower respiratory disease.

FIGURE 1

FIGURE 1

Association between Hearing loss and all cause and specific-cause mortality. Effect estimates are from the fully adjusted Model 4 that includes the covariates of age, sex, education, physical activity, smokers, alcohol intakes, body mass index, hypertension, diabetes, cancer, stroke, and coronary heart disease. Whiskers represent 95% confidence intervals, (United States, 2004–2013).

Subgroup Analyses

In terms of mortality results, a significant interaction was found between all covariates with HL. Compare people with HL diagnosed before the age of 45 vs. after the age of 45, the HL is related to the risk of all-cause mortality to those at the age of >45 years. For all-cause mortality, hearing loss risk at the age of >65 in little trouble, a lot of trouble and deaf were increased by 19% (HR1.19, 95% CI1.16-1.23), 52% (HR1.52, 95% CI 1.46–1.58), and 62% (HR1.62, 95% CI 1.42–1.84), (p < 0.001). Adults older than 65 years were associated with the highest all-cause mortality risk in those participants who were deaf. In the subgroup analysis according to these covariates (Table 3), for the same hearing condition, among the older adults (versus young adults), women (versus man), more than high school degreed adults (versus low school degree), <25 kg/m2 (versus >25 kg/m2), never cigarette (versus former and current smokers), lifetime abstainer (versus former drinker and current drinker) were associated with greatest risk of all-cause mortality.

TABLE 3

Subgroups Good Little trouble A lot of trouble Deaf
HR Lower Upper p HR (95%CI) p HR (95%CI) p HR (95%CI) p
Age group (years)
18–45 1.00 1.02 (0.92–1.13) 0.72 1.13 (0.86–1.50) 0.38 0.73 (0.34–1.58) 0.42
45–65 1.00 1.06 (1.01–1.11) 0.03 1.17 (1.05–1.30) 0.00 1.36 (1.00–1.86) 0.05
65- 1.00 1.19 (1.16–1.23) 0.00 1.52 (1.46–1.58) 0.00 1.62 (1.42–1.84) 0.00
Sex
Male 1.00 1.13 (1.09–1.16) 0.00 1.36 (1.29–1.43) 0.00 1.54 (1.32–1.80) 0.00
Female 1.00 1.21 (1.17–1.26) 0.00 1.63 (1.54–1.73) 0.00 1.57 (1.31–1.87) 0.00
Education level
Less than high school degree 1.00 1.16 (1.12–1.21) 0.00 1.41 (1.33–1.50) 0.00 1.50 (1.26–1.78) 0.00
High school degree 1.00 1.16 (1.11–1.21) 0.00 1.46 (1.36–1.57) 0.00 1.50 (1.23–1.84) 0.00
More than high school degree 1.00 1.17 (1.13–1.22) 0.00 1.49 (1.39–1.60 0.00 1.73 (1.41–2.11) 0.00
BMI (kg/m2)
<25 1.00 1.21 (1.16–1.25) 0.00 1.50 (1.42–1.59) 0.00 1.57 (1.33–1.86) 0.00
25–30 1.00 1.16 (1.11–1.21) 0.00 1.44 (1.35–1.53) 0.00 1.58 (1.27–1.97) 0.00
>30 1.00 1.08 (1.02–1.14) 0.00 1.36 (1.25–1.47) 0.00 1.37 (1.08–1.73) 0.01
Smoking status
Never cigarette 1.00 1.23 (1.19–1.28) 0.00 1.64 (1.54–1.75) 0.00 1.53 (1.25–1.88) 0.00
Former cigarette 1.00 1.13 (1.09–1.17) 0.00 1.39 (1.30–1.47) 0.00 1.67 (1.42–1.96) 0.00
Current cigarette 1.00 1.09 (1.03–1.15) 0.00 1.21 (1.09–1.34) 0.00 1.15 (0.88–1.51) 0.30
Alcohol intake
Lifetime abstainer 1.00 1.21 (1.15–1.27) 0.00 1.56 (1.46–1.66) 0.00 1.51 (1.22–1.86) 0.00
Former drinker 1.00 1.12 (1.08–1.17) 0.00 1.33 (1.24–1.43) 0.00 1.60 (1.32–1.93) 0.00
Current drinker 1.00 1.16 (1.12–1.20) 0.00 1.48 (1.39–1.58) 0.00 1.53 (1.24–1.88) 0.00
Physical activity
Yes 1.00 1.14 (1.09–1.20 0.00 1.35 (1.23–1.48) 0.00 1.51 (1.18–1.94) 0.00
No 1.00 1.17 (1.13–1.20) 0.00 1.47 (1.41–1.54) 0.00 1.54 (1.36–1.75) 0.00
Hypertension
Yes 1.00 1.15 (1.11–1.19) 0.00 1.41 (1.34–1.48) 0.00 1.49 (1.28–1.72) 0.00
No 1.00 1.17 (1.12–1.21) 0.00 1.51 (1.42–1.60) 0.00 1.59 (1.35–1.87) 0.00
Diabetes
Yes 1.00 1.12 (1.06–1.19) 0.00 1.31 (1.20–1.43) 0.00 1.53 (1.22–1.93) 0.00
No 1.00 1.17 (1.14–1.20) 0.00 1.49 (1.43–1.56) 0.00 1.55 (1.36–1.76) 0.00
CHD
Yes 1.00 1.09 (1.03–1.16) 0.00 1.30 (1.19–1.41) 0.00 1.39 (1.07–1.81) 0.01
No 1.00 1.17 (1.14–1.21) 0.00 1.50 (1.43–1.57) 0.00 1.59 (1.40–1.80) 0.00
Stroke
Yes 1.00 1.09 (1.01–1.16) 0.02 1.24 (1.12–1.37) 0.00 1.35 (1.01–1.83) 0.05
No 1.00 1.17 (1.14–1.20) 0.00 1.49 (1.43–1.55) 0.00 1.55 (1.37–1.76) 0.00
Cancer
Yes 1.00 1.10 (1.05–1.15) 0.00 1.34 (1.24–1.45) 0.00 1.48 (1.16–1.89) 0.00
No 1.00 1.18 (1.14–1.21) 0.00 1.49 (1.42–1.55) 0.00 1.54 (1.35–1.76) 0.00

Subgroup analyses of hearing loss adults for All-Cause Mortality, (United States, 2004–2013).

Cox proportional hazards regression models were adjusted for sex, age, education, body mass index, smokers, Alcohol intakes, and chronic conditions when appropriate.

Sensitivity Analyses

In order to confirm the results of the study, we performed two sensitivity analyses. Firstly, participants with chronic diseases had little effect on risk estimates of all-cause mortality were excluded (little trouble: 1.19 (1.16–1.23); a lot of trouble: 1.59 (1.61–1.67); deaf: 1.66 (1.42–1.94). Secondly, all deaths within 2 years of follow-up were excluded [little trouble: 1.17 (1.14–1.20); a lot of trouble: 1.44 (1.38–1.50); deaf: 1.61 (1.43–1.82)] (Supplementary Tables S2A,B).

Discussion

We used a large number of nationally representative samples of US adults and found that with severity of HL was significantly associated with higher risk of all-cause mortality. Age is an important factor in HL, and the risk of HL increases with age. Participants who reported having little trouble and a lot of trouble in HL had a higher risk for CVD mortality.

Consistent with our studies, most studies have shown that HL in the elderly is correlated with all cause mortality. To our knowledge, these studies as follows: The follow-up of the Norwegian samples rivaled studied association between HL and mortality. A representative Study revealed that HL was associated with a 20% increased mortality risk among 1,958 adults aged 70–79 years [18]. One study showed HL is largely dependent on age and that increased age and extended longevity may increase dramatically in the population that experiences HL [32]. The other study revealed that older adults, aged 80–84 have a higher proportion of HL, and HL largely depends on age [33]. Even after adjusting for other important risk factors, age remains the strongest predictor of HL [34]. In particular, data extracted from the NHANES cohort study showed statistically significant increase for all cause mortality among those a lot of trouble on HL. However, we find this association weakened after adjustment for demographics and chronic disease factors, which was almost the same as that in our study [5]. A previous study also proved that HL is related to mortality, which is consistent with our findings. Appollonio believes that the high mortality risk of HL in the elderly is related to physical health and social function [35]. Because of the serious HL of the elderly, the elderly have a low sense of social participation and social isolation and social loneliness, which accelerate the death risk of the elderly [36]. HL may increase the risk of physical and mental diseases through the physiological system that mediates the response to environmental threats in the elderly and people with severe HL are more likely to develop diseases that may be stress-mediated [37]. Previous studies have shown that hearing aids and cochlear implants are currently effective treatments for the elderly with HL, although patients are often underutilized [38]. However, compared with elderly people who don’t use hearing aids, elderly people who use hearing aids have a much lower chance of depressive symptoms. At the same time, HL usually coexists with tinnitus, so that means that hearing aids amplify external sounds will reduce the perception of tinnitus sounds and related problems [39]. For patients with specific hearing characteristics, hearing aids are beneficial, and the provision of hearing aids will always have the potential to reduce the distress associated with HL [40]. Whether the use of hearing aids and cochlear implants for hearing rehabilitation affects the risk of death in older adults with HL remains uncertain, and further research is needed. This will make “a lot of hearing difficulty” and “profoundly deaf” groups that seem to have about the same mortality rate in many places.

Although the underlying mechanism for the association between HL and mortality is unclear, the following reasons can be considered. The risk factors that increase the risk of death from HL are mainly related to such as smoking, physical activity, occupational noise exposure, and cardiovascular disease and other chronic diseases. Many studies have shown that men have a higher risk of death from HL than women with HL [33, 41]. The main reason is not only that men may be more affected by occupational noise, but also that men have a high smoking rate, which increases the risk of HL [42]. Smoking has always been an important risk factor affecting the health of U.S. adults, and the smoking rate in the United States has also greatly increased [43]. The association between smoking and HL has been confirmed in some other clinical studies [44, 45]. In our study, former smokers increase the risk of mortality with the severity of HL. As lifelong non-smokers sample are 56.5% and the smokers are 43.5% in our study. This sample limits our research on the association between smokers and lifelong non-smoker in HL condition. However, smoking is related to other lifestyles that may adversely affect health. Another study found that participants who do not engage in physical activities have an increased risk of death caused by HL in different hearing levels [46]. As reported previously, severe hearing loss is also associated with slower walking speed [47]. However, as we all know, in the United States and elsewhere, men of all ages have higher incidence and death of CHD than women according to the literature [48, 49]. A previous epidemiological study showed a significant association between elderly patients with HL and CVD mortality [15]. In our study, we can clearly find that without any covariate adjustment, adults with CVD have a higher risk of death than without CVD death. After adjusting the covariates’ results reflect that the HR of deaf patients with CVD risk is reduced. In a few studies, it is demonstrated that HL is related to CHD, and it had a positive association of CHD with the deaf population. Wen Qi Gan et.al. found that exposure to loud occupational noise was significantly associated with the presence of CHD. HL is also a severely indicator for chronic exposure to loud noise [50, 51].

In terms of cause-specific mortality, a similar study from NHIS data found that the association between HL and cause-specific mortality may indirectly increase the risk of mortality due to increased accidental death [52]. However, we did not observe a significant association between HL and accidental death. It was reported that HL is related to cancer events. In addition, another study also analyzed the high mortality of HL patients may also be the existence of chronic diseases [53]. We also adjusted the health status of chronic diseases to modify the effect of HL on mortality in this study. A study on the relationship between increased stroke prevalence and HL in older adults is significant [54]. Some other studies have provided that HL is related to the risk of stroke and stroke-related death. It was observed in one of those studies that adults, age 65 and older, with HL are more likely to suffer from stroke [51, 55]. Our research shows that HL is not only related to all-cause mortality, but also related to each cause-specific mortality. Since HL is a serious threat to the health of people, our research has important public health significance, and more effective measures should be taken to prevent hearing loss.

Findings of This Study

In our study, in addition to previous studies in which HL was associated with all-cause mortality, we determined whether HL was associated with mortality due to CVD; heart disease; stroke; CLRD; cancer; diabetes; Alzheimer’s disease; influenza and pneumonia; and accidents. Our study confirmed that hearing loss was associated not only with all-cause mortality, but also with specific mortality for each cause. Our subgroup analysis found that for the same hearing condition, in older adults, women, high school education and above, and lifetime alcohol abuse were associated with an increased risk of all-cause mortality, and these important findings could be important for our prevention of HL. Our findings have important public health implications as they suggest that future recommendations could be expanded to preventing or inhibiting the pathogenic factors of hearing loss is important for reducing the risk of death.

Our study has several advantages. First, this study is a prospective cohort study, and the data come from a large sample of representative US adults. NHIS aims to represent the US population and the survey response rate is extremely high (95%–98%). In addition, we constantly adjusted the potential confounding factors in the model and conduct subgroup and sensitivity analysis to ensure the reliability of this study. Some restrictions should be noted. Firstly, the state of HL is obtained self-reported questionnaires of participants, which may cause recall bias. We still cannot completely exclude the remaining confounding factors. 7.5% of the total cohort was excluded (n = 37,038/493,036 participants) were excluded owing to missing data on exposures or covariates, as well as hearing loss who are answered by other family members, which might have led to bias if those excluded differed from those not excluded. The results might not be adapted to children. Besides, age available only is a three-level ordinal variable in the US dataset. Secondly, this study did not include non-fatal events, which limited our ability to estimate the risk of incident diseases. Thirdly, I do not have data on the hearing aids and/or cochlear implants available, poor communication between doctors and hearing loss patients results in a variety of adverse outcomes.

Conclusion

In the present study, elderly participants with extreme HL (deaf patients) are associated with increased risk of all-cause and cause-specific mortality. The findings of our research and the growing literature have also revealed the potential burden of HL and consequences, and it is necessary to improve the screening and management of HL among U.S. adults, especially among the elderly.

Statements

Data Availability Statement

The NHIS data are available from www.cdc.gov/nchs/nhis/index.htm.

Author Contributions

YC and YY are responsible for conceptualizing the research theme, data collection and analysis, interpretation of the results, the integrity and accuracy of the analysis, and drafted earlier versions of the manuscript. All authors read and approved the final version.

Funding

This study was supported by the Fundamental Research Funds for the Central Universities of Central South University.

Acknowledgments

All authors thank the NCHS of the Centers for Disease Control and Prevention for sharing the NHIS data.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.ssph-journal.org/articles/10.3389/ijph.2022.1604785/full#supplementary-material

References

  • 1

    World Health Organization. Deafness and Hearing Loss. Geneva: World Health Organization (2018).

  • 2

    World Health Organization. Addressing the Rising Prevalence of Hearing Loss. Geneva: World Health Organization (2018).

  • 3

    Yuri A Platz EA Niparko JK . Prevalence of Hearing Loss and Differences by Demographic Characteristics Among US Adults: Data from the National Health and Nutrition Examination Survey, 1999-2004. Arch Intern Med (2008) 168(14):152230.

  • 4

    Mahboubi H Lin HW Bhattacharyya N . Prevalence, Characteristics, and Treatment Patterns of Hearing Difficulty in the United States. JAMA Otolaryngol Head Neck Surg (2018) 144:65. 10.1001/jamaoto.2017.2223

  • 5

    Contrera KJ Betz J Genther DJ Lin FR . Association of Hearing Impairment and Mortality in the National Health and Nutrition Examination Survey. JAMA Otolaryngol Head Neck Surg (2015) 141:944. 10.1001/jamaoto.2015.1762

  • 6

    Wallhagen MI Strawbridge WJ Cohen RD Kaplan GA . An Increasing Prevalence of Hearing Impairment and Associated Risk Factors over Three Decades of the Alameda County Study. Am J Public Health (1997) 87(3):4402. 10.2105/ajph.87.3.440

  • 7

    Morata TC . Young People: Their Noise and Music Exposures and the Risk of Hearing Loss. Int J Audiol (2007) 46(3):1112. 10.1080/14992020601103079

  • 8

    Zhan W Cruickshanks KJ Klein BEK Klein R Huang G-H Pankow JS et al Generational Differences in the Prevalence of Hearing Impairment in Older Adults. Am J Epidemiol (2010) 171(2):2606. 10.1093/aje/kwp370

  • 9

    Disease GBD . Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet (2018) 392(10159):1789858. 10.1016/S0140-6736(18)32279-7

  • 10

    Olusanya BO Davis AC Hoffman HJ . Hearing Loss: Rising Prevalence and Impact. Bull World Health Organ (2019) 97(10):646. 10.2471/BLT.19.224683

  • 11

    Ries PW . Prevalence and Characteristics of Persons with Hearing Trouble: United States, 1990-91. Vital Health Stat 10 (1994) 188(188):175.

  • 12

    Moscicki EK Elkins EF Baurn HM McNarnara PM . Hearing Loss in the Elderly. Ear Hearing (1985) 6(4):18490. 10.1097/00003446-198507000-00003

  • 13

    Helzner EP Cauley JA Pratt SR Wisniewski SR Zmuda JM Talbott EO et al Race and Sex Differences in Age-Related Hearing Loss: The Health, Aging and Body Composition Study. J Am Geriatr Soc (2005) 53(12):211927. 10.1111/j.1532-5415.2005.00525.x

  • 14

    Karpa MJ Gopinath B Beath K Rochtchina E Cumming RG Wang JJ et al Associations between Hearing Impairment and Mortality Risk in Older Persons: The Blue Mountains Hearing Study. Ann Epidemiol (2010) 20(6):4529. 10.1016/j.annepidem.2010.03.011

  • 15

    Diana F Chuan-Ming L Chiu MS Themann CL Hannes P Friðbert J et al Impairments in Hearing and Vision Impact on Mortality in Older People: The AGES-Reykjavik Study. Age Agng. (2014) 43(1):6976. 10.1093/ageing/aft122

  • 16

    Lam BL . Concurrent Visual and Hearing Impairment and Risk of Mortality. Arch Ophthalmol (2006) 124(1):95. 10.1001/archopht.124.1.95

  • 17

    Reuben DB Mui S Damesyn M Moore AA Greendale GA . The Prognostic Value of Sensory Impairment in Older Persons. J Am Geriatr Soc (1999) 47(8):9305. 10.1111/j.1532-5415.1999.tb01286.x

  • 18

    Genther DJ Betz J Pratt S Kritchevsky SB Martin KR Harris TB et al Association of Hearing Impairment and Mortality in Older Adults. J Gerontol Ser A Biol Sci Med Sci (2015) 70(1):8590. 10.1093/gerona/glu094

  • 19

    Lin FR . Hearing Loss and Cognition Among Older Adults in the United States. J Gerontol A Biol Sci Med Sci (2011) 66(10):11316. 10.1093/gerona/glr115

  • 20

    Thomas PD Hunt WC Garry PJ Hood RB Goodwin JM Goodwin JS . Hearing Acuity in a Healthy Elderly Population: Effects on Emotional, Cognitive, and Social Status. J Gerontol (1983) 38(3):3215. 10.1093/geronj/38.3.321

  • 21

    Bess FH Lichtenstein MJ Logan SA Burger MC Nelson E . Hearing Impairment as a Determinant of Function in the Elderly. J Am Geriatr Soc (1989) 37(2):1238. 10.1111/j.1532-5415.1989.tb05870.x

  • 22

    Weinstein BE Ventry IM . Hearing Impairment and Social Isolation in the Elderly. J Speech Hear Res (1983) 25(4):5939. 10.1044/jshr.2504.593

  • 23

    Mick P Kawachi I Lin FR . The Association between Hearing Loss and Social Isolation in Older Adults. Otolaryngol Head Neck Surg (2014) 150(3):37884. 10.1177/0194599813518021

  • 24

    Chen DS Genther DJ Betz J Lin FR . Association between Hearing Impairment and Self-Reported Difficulty in Physical Functioning. J Am Geriatr Soc (2014) 62(5):8506. 10.1111/jgs.12800

  • 25

    Chang H-P Ho C-Y Chou P . The Factors Associated with a Self-Perceived Hearing Handicap in Elderly People with Hearing Impairment-Results from a Community-Based Study. Ear Hear (2009) 30(5):57683. 10.1097/aud.0b013e3181ac127a

  • 26

    Ramage-Morin PL . Hearing Difficulties and Feelings of Social Isolation Among Canadians Aged 45 or Older. Health Rep (2016) 27(11):312.

  • 27

    Tsimpida D Kontopantelis E Ashcroft DM Panagioti M . The Dynamic Relationship between Hearing Loss, Quality of Life, Socioeconomic Position and Depression and the Impact of Hearing Aids: Answers from the English Longitudinal Study of Ageing (ELSA). Soc Psychiatry Psychiatr Epidemiol (2021) 57:353. 10.1007/s00127-021-02155-0

  • 28

    Berrocal JRG Ramírez-Camacho R Portero F Vargas JA . Role of Viral andMycoplasma pneumoniaeInfection in Idiopathic Sudden Sensorineural Hearing Loss. Acta Oto Laryngol (2000) 120(7):8359. 10.1080/000164800750061688

  • 29

    Matsumura E Matas CG Sanches SGG Magliaro FCL Pedreño RM Genta PR et al Severe Obstructive Sleep Apnea is Associated with Cochlear Function Impairment. Sleep Breath (2018) 22(1):717. 10.1007/s11325-017-1530-5

  • 30

    National Center for Health Statistics, Centers for Disease Control and Prevention. The Linkage of National Center for Health Statistics Survey Data to the National Death Index-2015 Linked Mortality File (LMF): Methodology Overview and Analytic Considerations. (2017). www.cdc.gov/nchs/data/datalinkage/lmf2015_methodology_analytic_considerations.pdf

  • 31

    Lochner K Hummer RA Bartee S Wheatcroft G Cox C . The Public-Use National Health Interview Survey Linked Mortality Files: Methods of Reidentification Risk Avoidance and Comparative Analysis. Am J Epidemiol (2008) 168(3):33644. 10.1093/aje/kwn123

  • 32

    Engdahl B Idstad M Skirbekk V . Hearing Loss, Family Status and Mortality - Findings from the HUNT Study, Norway. Soc Sci Med (2019) 220:21925. 10.1016/j.socscimed.2018.11.022

  • 33

    Borchgrevink H Tambs K Hoffman H . The Nord-Trondelag Norway Audiometric Survey 1996-98 : Unscreened Thresholds and Prevalence of Hearing Impairment for Adults > 20 Years. Noise Health (2005) 7(28):115. 10.4103/1463-1741.31632

  • 34

    Hoffman HJ Dobie RA Losonczy KG Themann CL Flamme GA . Declining Prevalence of Hearing Loss in US Adults Aged 20 to 69 Years. JAMA Otolaryngol Head Neck Surg (2017) 143(3):27485. 10.1001/jamaoto.2016.3527

  • 35

    Ildebrando A Corrado C Lodovico F Marco T . Effects of Sensory Aids on the Quality of Life and Mortality of Elderly People: A Multivariate Analysis. Age Ageing (1996) 25:89.

  • 36

    Strawbridge WJ Wallhagen MI Shema SJ Kaplan GA . Negative Consequences of Hearing Impairment in Old Age. Gerontologist (2000) 40(3):3206. 10.1093/geront/40.3.320

  • 37

    Guitar K Giles E Raymond B Welch D . Health Effects of Cochlear Implants. N Z Med J (2013) 126(1375):926.

  • 38

    Choi JS Betz J Li L Blake CR Sung YK Contrera KJ et al Association of Using Hearing Aids or Cochlear Implants with Changes in Depressive Symptoms in Older Adults. JAMA Otolaryngol Head Neck Surg (2016) 142(7):6527. 10.1001/jamaoto.2016.0700

  • 39

    Hoare DJ Edmondson-Jones M Sereda M Akeroyd MA Hall D . Amplification with Hearing Aids for Patients with Tinnitus and Co-existing Hearing Loss. Cochrane Database Syst Rev (2014) 1(1):Cd010151. 10.1002/14651858.CD010151.pub2

  • 40

    Hoare DJ Searchfield GD El Refaie A Henry JA . Sound Therapy for Tinnitus Management: Practicable Options. J Am Acad Audiol (2014) 25(1):6275. 10.3766/jaaa.25.1.5

  • 41

    Contrera KJ Betz J Genther DJ Lin FR . Association of Hearing Impairment and Mortality in the National Health and Nutrition Examination Survey. JAMA Otolaryngol Head Neck Surg (2015) 141(10):9446. 10.1001/jamaoto.2015.1762

  • 42

    Zhan W Cruickshanks KJ Klein BE Klein R Huang GH Pankow JS et al Modifiable Determinants of Hearing Impairment in Adults. Prev Med (2011) 53(4-5):33842. 10.1016/j.ypmed.2011.08.012

  • 43

    Waldron I . Patterns and Causes of Gender Differences in Smoking. Soc Sci Med (1991) 32(9):9891005. 10.1016/0277-9536(91)90157-8

  • 44

    Weiss W . How Smoking Affects Hearing. Med Times (1970) 98(11):848.

  • 45

    Zelman S . Correlation of Smoking History with Hearing Loss. JAMA (1973) 223(8):920. 10.1001/jama.1973.03220080050016

  • 46

    Feng X Li W Cheng M Qiu W Liang R Li M et al Association of Hearing Loss with Total and Cause-specific Mortality in US Adults. Environ Sci Pollut Res Int (2021) 29:5032. 10.1007/s11356-021-16038-z

  • 47

    Li L Simonsick EM Ferrucci L Lin FR . Hearing Loss and Gait Speed Among Older Adults in the United States. Gait Posture (2013) 38(1):259. 10.1016/j.gaitpost.2012.10.006

  • 48

    Millett ERC Peters SAE Woodward M . Sex Differences in Risk Factors for Myocardial Infarction: Cohort Study of UK Biobank Participants. BMJ (2018) 363:k4247. 10.1136/bmj.k4247

  • 49

    Peters SAE Colantonio LD Dai Y Zhao H Bittner V Farkouh ME et al Trends in Recurrent Coronary Heart Disease after Myocardial Infarction Among US Women and Men between 2008 and 2017. Circulation (2021) 143(7):65060. 10.1161/circulationaha.120.047065

  • 50

    Gan WQ Moline J Kim H Mannino DM . Exposure to Loud Noise, Bilateral High-Frequency Hearing Loss and Coronary Heart Disease. Occup Environ Med (2016) 73:34. 10.1136/oemed-2014-102778

  • 51

    Fang Q Lai X Yang L Wang Z Zhan Y Zhou L et al Hearing Loss Is Associated with Increased Stroke Risk in the Dongfeng-Tongji Cohort. Atherosclerosis (2019) 285:106. 10.1016/j.atherosclerosis.2019.03.012

  • 52

    Lin HW Mahboubi H Bhattacharyya N . Hearing Difficulty and Risk of Mortality. Ann Otol Rhinol Laryngol (2019) 128:614. 10.1177/0003489419834948

  • 53

    Barnett S Franks P . Deafness and Mortality: Analyses of Linked Data from the National Health Interview Survey and National Death Index. Public Health Rep (1999) 114(4):3306. 10.1093/phr/114.4.330

  • 54

    Gopinath B Schneider J Rochtchina E Leeder SR Mitchell P . Association between Age-Related Hearing Loss and Stroke in an Older Population. Stroke (2009) 40(4):14968. 10.1161/strokeaha.108.535682

  • 55

    Liljas AEM Wannamethee SG Whincup PH Papacosta O Walters K Iliffe S et al Socio-demographic Characteristics, Lifestyle Factors and burden of Morbidity Associated with Self-Reported Hearing and Vision Impairments in Older British Community-Dwelling Men: a Cross-Sectional Study. J Public Health (2016) 38(2):e21e28. 10.1093/pubmed/fdv095

Summary

Keywords

mortality, hearing loss, all-cause, cause-specific, US adults, prospective cohort study

Citation

Cui Y and Yan Y (2022) Association of all Cause and Cause-Specific Mortality With Hearing Loss Among US Adults: A Secondary Analysis Study. Int J Public Health 67:1604785. doi: 10.3389/ijph.2022.1604785

Received

21 January 2022

Accepted

26 April 2022

Published

17 May 2022

Volume

67 - 2022

Edited by

Nino Kuenzli, Swiss Tropical and Public Health Institute (Swiss TPH), Switzerland

Updates

Copyright

*Correspondence: Yan Yan,

This Original Article is part of the IJPH Special Issue “Health in All Sustainable Development Goals”

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article